<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on European Commission</title><link href="http://biotechresearchinfo.com/topic/european-commission" rel="alternate"></link><id>http://biotechresearchinfo.com/topic/european-commission</id><updated>2011-10-11T06:00:25Z</updated><entry><title>EU sets out tough rules on medicines information</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-sets-tough-rules-medicines-information-4842601a" rel="alternate"></link><updated>2011-10-11T06:00:25Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:biotechresearchinfo.com,2011-10-11:/pharmaceuticals-sector/eu-sets-tough-rules-medicines-information-4842601a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;LONDON&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - &lt;span&gt;&lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt;&lt;/span&gt; will strictly limit the amount of information that drugmakers can supply to the public on prescription-only medicines and retain a ban on advertising under proposed rules set out on Tuesday.&lt;/p&gt;&lt;p&gt;The latest proposals from the &lt;span&gt;&lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commissio...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="New Zealand"></category><category term="Vioxx"></category><category term="Reuters Group plc"></category><category term="Oceania"></category><category term="David Holmes"></category><category term="European Consumers' Organisation"></category><category term="Federation of Pharmaceutical"></category></entry><entry><title>Are patent deals slowing cheaper drugs?</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/patent-deals-slowing-cheaper-drugs-4730542a" rel="alternate"></link><updated>2011-01-17T13:00:09Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:biotechresearchinfo.com,2011-01-17:/pharmaceuticals-sector/patent-deals-slowing-cheaper-drugs-4730542a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt;&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - The &lt;span&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;&lt;/span&gt; regulator said on Monday it was pressing pharmaceutical companies for more information on their patent deals with generic companies to make sure there is no delay in cheaper drugs coming to market.&lt;/p&gt;&lt;p&gt;The move is the latest in a series of EU crackd...</summary><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Switzerland"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="Joaquin Almunia"></category></entry><entry><title>Milk and meat from cloned animals declared safe</title><link href="http://biotechresearchinfo.com/cloning/milk-meat-cloned-animals-declared-safe-4434542a" rel="alternate"></link><updated>2010-11-29T14:47:02Z</updated><author><name>New Scientist</name></author><id>tag:biotechresearchinfo.com,2010-11-29:/cloning/milk-meat-cloned-animals-declared-safe-4434542a/</id><summary type="html">...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="British Politics"></category><category term="EU Politics"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Food Safety"></category><category term="United States"></category><category term="The New York Times Company"></category><category term="United Kingdom"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="Asia"></category><category term="South America"></category><category term="Western Europe"></category><category term="British Broadcasting Corporation"></category><category term="Soil Association"></category><category term="Food Standards Agency"></category><category term="Genetic Engineering"></category><category term="Andrew Wadge"></category><category term="Dairy and Eggs"></category><category term="Committee on Novel Foods"></category></entry><entry><title>EU exec proposes ban on animal cloning for food</title><link href="http://biotechresearchinfo.com/cloning/eu-exec-proposes-ban-animal-cloning-food-2153256a" rel="alternate"></link><updated>2010-10-22T13:29:37Z</updated><author><name>Reuters Environmental Online Report</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/cloning/eu-exec-proposes-ban-animal-cloning-food-2153256a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt;&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; announced plans on Tuesday to temporarily ban the use of animal cloning for food production, while allowing imports of food derived from the offspring of clones from the &lt;span&gt;&lt;a title="United States" href="/topic/United+States" &gt;United States&lt;/a&gt;&lt;/spa...</summary><category term="Trade"></category><category term="Imports and Exports"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Social Issues"></category><category term="Animal Rights"></category><category term="Food and Beverage Sector"></category><category term="Food Manufacturing"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Brazil"></category><category term="South America"></category><category term="Western Europe"></category><category term="Scotland"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="European Parliament"></category><category term="Genetic Engineering"></category><category term="Imports"></category></entry><entry><title>Teva Receives European Commission Approval for ratiopharm Acquisition</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/teva-receives-european-commission-approval-ratiopharm-acquisition-3516266a" rel="alternate"></link><updated>2010-11-02T12:39:46Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-11-02:/pharmaceuticals-sector/teva-receives-european-commission-approval-ratiopharm-acquisition-3516266a/</id><summary type="html">...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="North America"></category><category term="Medicaid"></category><category term="Medicare"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Israel"></category><category term="Europe"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="Middle East"></category><category term="European Medicines Agency"></category><category term="Copaxone"></category><category term="Neurontin"></category><category term="Lotrel"></category><category term="Ratiopharm GmbH"></category><category term="Teva Pharmaceutical Industries Ltd."></category><category term="Protonix"></category><category term="Kevin Mannix"></category><category term="Private Securities Litigation Reform Act"></category><category term="Elana Holzman Teva Pharmaceutical Industries Ltd."></category><category term="Yossi Koren Teva Pharmaceutical Industries Ltd."></category><category term="Willkie Farr &amp; Gallagher LLP"></category></entry><entry><title>AstraZeneca loses generic drug case versus EU</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/astrazeneca-loses-generic-drug-case-eu-980044a" rel="alternate"></link><updated>2010-09-22T13:56:16Z</updated><author><name>Reuters US Online Report Business News</name></author><id>tag:biotechresearchinfo.com,2010-09-22:/pharmaceuticals-sector/astrazeneca-loses-generic-drug-case-eu-980044a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; court backed an EU antitrust decision against Anglo-Swedish drugmaker &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; Thursday, lending weight to a regulatory crackdown on firms blocking cheaper drugs coming to market.&lt;/p&gt;&lt;p&gt;Antitrust lawyers said th...</summary><category term="Stock Prices"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Norway"></category><category term="Denmark"></category><category term="Germany"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="Nordic Countries"></category><category term="Boehringer Ingelheim GmbH"></category><category term="Losec"></category><category term="Sarah Lindgreen"></category><category term="Ben Deighton"></category><category term="David Cowell"></category><category term="Nicola Dagg"></category></entry><entry><title>Fury as Brussels authorises GM potatoes</title><link href="http://biotechresearchinfo.com/biotechnology/fury-brussels-authorises-gm-potatoes-860933a" rel="alternate"></link><updated>2010-03-03T08:16:18Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-03-03:/biotechnology/fury-brussels-authorises-gm-potatoes-860933a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; on Tuesday approved the cultivation of genetically-modified potatoes, prompting an angry response from environmental campaign groups and two &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; member governments.&lt;/p&gt;&lt;p&gt;&lt;a title="Austria" href="/topic/Austria" &gt;Austria&lt;/a&gt; said it was planning an immediate ban on the potatoes' cultivation, while &lt;a title="Italy" href="/topic/Italy" &gt;It...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Fruits and Vegetables"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="European Union"></category><category term="Italy"></category><category term="Europe"></category><category term="European Commission"></category><category term="Austria"></category><category term="Central Europe"></category><category term="Monsanto Company"></category><category term="Greenpeace International"></category><category term="Friends of the Earth"></category><category term="Southern Europe"></category><category term="Luca Zaia"></category><category term="Marco Contiero"></category><category term="BASF SE"></category><category term="Alois Stoeger"></category><category term="John Dalli"></category></entry><entry><title>Biotech's Latest Failed Trials, Mishaps and Missed Targets</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/biotechs-latest-failed-trials-mishaps-missed-targets-2776178a" rel="alternate"></link><updated>2010-10-22T13:11:03Z</updated><author><name>SeekingAlpha</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/pharmaceuticals-sector/biotechs-latest-failed-trials-mishaps-missed-targets-2776178a/</id><summary type="html">...</summary><category term="Jobs and Labor"></category><category term="Layoffs and Downsizing"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="U.S. Securities and Exchange Commission"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Canada"></category><category term="Food and Drug Administration"></category><category term="Belgium"></category><category term="Asia"></category><category term="Pennsylvania"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Indianapolis"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Reuters Group plc"></category><category term="Charles River Laboratories International Inc."></category><category term="Boehringer Ingelheim GmbH"></category><category term="The Medicines Company"></category><category term="Shawinigan"></category><category term="Shrewsbury (Massachusetts)"></category><category term="Lonza Group AG"></category><category term="Recordati SpA"></category><category term="Carbaglu"></category></entry><entry><title>Industry prepares to go digital in 2009</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/industry-prepares-digital-2009-2758234a" rel="alternate"></link><updated>2010-10-22T12:09:23Z</updated><author><name>The Encyclopedia Britannica</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/pharmaceuticals-sector/industry-prepares-digital-2009-2758234a/</id><summary type="html">...</summary><category term="Media"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Commission"></category><category term="British Broadcasting Corporation"></category><category term="National Institute for Health and Clinical Excellence"></category><category term="Catherine Warne"></category><category term="Marc Southern"></category></entry><entry><title>Novartis subsidiary Sandoz raided by EU</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/novartis-subsidiary-sandoz-raided-eu-696314a" rel="alternate"></link><updated>2010-04-16T09:57:02Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/novartis-subsidiary-sandoz-raided-eu-696314a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Swiss pharmaceutical giant &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis&lt;/a&gt; said on Wednesday that offices of its subsidiary Sandoz were raided by &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; investigators probing suspected competition violations.&lt;/p&gt;&lt;p&gt;"The French offices of Sandoz were raided" on Tuesday, a Novartis spokesman said, without giving further details.&lt;/p&gt;&lt;p&gt;He added that European authorities had not sought further i...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Germany"></category><category term="Europe"></category><category term="European Commission"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Ratiopharm GmbH"></category></entry><entry><title>Public-Private Partnerships: A Recipe For Success?</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/publicprivate-partnerships-recipe-success-3363210a" rel="alternate"></link><updated>2010-10-26T23:20:32Z</updated><author><name>Science</name></author><id>tag:biotechresearchinfo.com,2010-10-26:/pharmaceuticals-sector/publicprivate-partnerships-recipe-success-3363210a/</id><summary type="html">...</summary><category term="Medical Treatments and Procedures"></category><category term="Pain Management"></category><category term="Sciences"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="United Kingdom"></category><category term="Italy"></category><category term="Europe"></category><category term="Barcelona"></category><category term="Spain"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="Switzerland"></category><category term="France"></category><category term="Madrid"></category><category term="Eli Lilly and Company"></category><category term="Critical Path Inc."></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Munich"></category><category term="Rolls-Royce plc"></category><category term="Chichester"></category><category term="Dortmund"></category><category term="Silvio Berlusconi"></category><category term="Max Planck Society"></category><category term="Max Planck"></category><category term="Southern Europe"></category><category term="England"></category><category term="Euroscience"></category><category term="Snecma SA"></category><category term="MTU Aero Engines GmbH"></category><category term="London (England)"></category><category term="Berlin (Germany)"></category><category term="Institute for Research in Biomedicine"></category><category term="AAAS/Science Business Office"></category><category term="Gunjan Sinha"></category><category term="Nanoelectronics Technologies"></category><category term="Eric Dautriat"></category><category term="Joan Guinovart"></category><category term="Jacky Vonderscher"></category><category term="Peter Tindemans"></category><category term="Benedikt Wolbeck"></category><category term="National Strategic Consortiums for Technological Research"></category><category term="Catharine Ray"></category><category term="Frieder Meyer-Krahmer"></category><category term="Inventive Capital Advisor LLP"></category></entry><entry><title>Pharmaceuticals ampfine chemicals</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/pharmaceuticals-ampfine-chemicals-2743320a" rel="alternate"></link><updated>2010-10-22T11:29:29Z</updated><author><name>The Encyclopedia Britannica</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/pharmaceuticals-sector/pharmaceuticals-ampfine-chemicals-2743320a/</id><summary type="html">...</summary><category term="Marketing"></category><category term="Market Research"></category><category term="Crime"></category><category term="Counterfeiting"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Irish Politics"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Advertising and Related Services"></category><category term="Europe"></category><category term="European Commission"></category><category term="Ireland"></category><category term="Research and Markets Ltd."></category><category term="Dublin (Ireland)"></category></entry><entry><title>EU warns of antitrust probes into drug makers</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-warns-antitrust-probes-drug-makers-586513a" rel="alternate"></link><updated>2010-06-11T20:18:15Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-06-11:/pharmaceuticals-sector/eu-warns-antitrust-probes-drug-makers-586513a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; warned Wednesday of a wave of antitrust investigations into major drugmakers, saying they were deliberately stalling cheaper generic versions of their own medicines once exclusive patents expire.&lt;/p&gt;&lt;p&gt;"Makers of original medicines are actively trying to delay the entry of generic medicines onto their markets," &lt;a title="Neelie Kroes" href="/topic/Neelie+Kroes" &gt;EU Competition Commissioner Neelie Kroes&lt;/a&gt; sai...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New Jersey"></category><category term="Trenton"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="The Associated Press"></category><category term="Neelie Kroes"></category><category term="Linda Johnson"></category><category term="Sandoz International GmbH"></category><category term="Stephen Rea"></category><category term="Losec"></category><category term="Servier Laboratories SA"></category><category term="Niche Generics Ltd."></category><category term="Oliver Stohlmann"></category><category term="London (England)"></category></entry><entry><title>EU probes pharma industry over generic medicine concerns</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-probes-pharma-industry-generic-medicine-concerns-586882a" rel="alternate"></link><updated>2010-04-16T11:26:39Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-probes-pharma-industry-generic-medicine-concerns-586882a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt;'s competition regulator launched a probe into the pharmaceutical sector Wednesday over concerns that cheap generic medicines are not reaching patients in need.&lt;/p&gt;&lt;p&gt;The move came after a sector-wide report showed that the number of new drugs reaching the market annually had dropped by over a third since 2000 and that people are being deprived of innovative, affordable and safe medicine.&lt;/p&gt;&lt;p&gt;The competition ...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Neelie Kroes"></category><category term="Monique Goyens"></category><category term="European Consumers' Organisation"></category><category term="Servier Laboratories SA"></category><category term="European Federation of Pharmaceutical Industries"></category><category term="European Generic Medicines Association"></category></entry><entry><title>EU to examine Pfizer takeover of rival Wyeth</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-examine-pfizer-takeover-rival-wyeth-546674a" rel="alternate"></link><updated>2010-04-16T12:00:03Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-examine-pfizer-takeover-rival-wyeth-546674a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;'s competition services will examine US drug manufacturer &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer Inc&lt;/a&gt;'s takeover of rival Wyeth, the largest pharmaceutical takeover deal in nearly a decade, the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; announced Tuesday.&lt;/p&gt;&lt;p&gt;The EU Commission will give its opinion on July 6 on whether the deal breaches European competit...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Cholesterol"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Viagra"></category><category term="Lipitor"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Brussels"></category><category term="Warner-Lambert Corporation"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>UPDATE 1-EU report slams drug industry practices -source</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/update-1eu-report-slams-drug-industry-practices-source-2312316a" rel="alternate"></link><updated>2010-10-21T09:45:23Z</updated><author><name>Forbes</name></author><id>tag:biotechresearchinfo.com,2010-10-21:/pharmaceuticals-sector/update-1eu-report-slams-drug-industry-practices-source-2312316a/</id><summary type="html">...</summary><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Pfizer Inc."></category><category term="Bayer AG"></category><category term="Sanofi-Aventis SA"></category><category term="Reuters Group plc"></category><category term="Teva Pharmaceutical Industries Ltd."></category><category term="Neelie Kroes"></category><category term="Losec"></category><category term="European Federation of Pharmaceutical Industries"></category></entry><entry><title>EU panel OKs 2 genetically modified corn products</title><link href="http://biotechresearchinfo.com/biotechnology/eu-panel-oks-2-genetically-modified-corn-products-504135a" rel="alternate"></link><updated>2010-10-22T10:10:19Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/biotechnology/eu-panel-oks-2-genetically-modified-corn-products-504135a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; food safety agency panel approves 2 genetically modified corn products&lt;/div&gt;&lt;div&gt;&lt;p&gt;The European Union's food safety agency approved two genetically modified corns Friday, putting renewed pressure on EU nations to drop their objections to the use of biotech crops.&lt;/p&gt;&lt;p&gt;Scientists at the &lt;a title="Parma" href="/topic/Parma" &gt;Parma&lt;/a&gt;, &lt;a title="Italy" href="/topic/Italy" &gt;Italy&lt;/a&gt;-based &lt;a title="European Food Sa...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Food Safety"></category><category term="Crop Production"></category><category term="United States"></category><category term="European Union"></category><category term="Italy"></category><category term="Europe"></category><category term="European Commission"></category><category term="Switzerland"></category><category term="Austria"></category><category term="France"></category><category term="Western Europe"></category><category term="Poland"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Central Europe"></category><category term="Parma"></category><category term="Mike Hall"></category><category term="Monsanto Company"></category><category term="Greenpeace International"></category><category term="Syngenta Corporation"></category><category term="European Food Safety Authority"></category><category term="Southern Europe"></category><category term="Pioneer Hi-Bred International Inc."></category><category term="Marta Vetier"></category><category term="Genetic Engineering"></category><category term="Genetically Modified Organisms"></category><category term="Consumer Non-Cyclicals"></category></entry><entry><title>UPDATE 1-EU says Zentiva/Sanofi deal notification incomplete</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/update-1eu-zentivasanofi-deal-notification-incomplete-2306021a" rel="alternate"></link><updated>2010-10-21T09:41:59Z</updated><author><name>Forbes</name></author><id>tag:biotechresearchinfo.com,2010-10-21:/pharmaceuticals-sector/update-1eu-zentivasanofi-deal-notification-incomplete-2306021a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Mergers and Acquisitions"></category><category term="Takeovers"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Brussels"></category><category term="Zentiva NV"></category></entry><entry><title>NHS drug bill faces EU threat</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/nhs-drug-bill-faces-eu-threat-456239a" rel="alternate"></link><updated>2010-04-16T13:18:56Z</updated><author><name>guardian.co.uk</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/nhs-drug-bill-faces-eu-threat-456239a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The NHS's &amp;amp;amp;amp;pound;11bn annual bill for drugs could soar if pharmaceutical companies are allowed to start pushing promotional 'information' about their products directly to patients, claim health and consumer groups.&lt;/p&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; will next month unveil plans to let drug firms use the media to give information about prescription-only medicines. But opponents argue the controversial proposals would come close...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="European Commission"></category><category term="British Medical Association"></category><category term="Royal College of Physicians"></category><category term="Association of the British Pharmaceutical Industry"></category><category term="Pete Moorey"></category></entry><entry><title>Antitrust: EU Commission Opens Formal Proceedings Against
Sanofi-Aventis for Possible Procedural Infringement</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/antitrust-eu-commission-opens-formal-proceedings-against0Asanofiaventis-procedural-infringement-2947509a" rel="alternate"></link><updated>2010-10-23T15:58:19Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-10-23:/pharmaceuticals-sector/antitrust-eu-commission-opens-formal-proceedings-against0Asanofiaventis-procedural-infringement-2947509a/</id><summary type="html">...</summary><category term="Crime"></category><category term="Politics"></category><category term="Political Policy"></category><category term="International Relations"></category><category term="Diplomacy"></category><category term="Treaties"></category><category term="World Politics"></category><category term="European Politics"></category><category term="French Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Europe"></category><category term="European Commission"></category><category term="France"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category></entry><entry><title>Could the calves of Britain's first cloned cow get lost in the food chain?</title><link href="http://biotechresearchinfo.com/cloning/calves-britains-cloned-cow-lost-food-chain-2169704a" rel="alternate"></link><updated>2010-10-19T10:11:03Z</updated><author><name>ThisIsLondon.co.uk</name></author><id>tag:biotechresearchinfo.com,2010-10-19:/cloning/calves-britains-cloned-cow-lost-food-chain-2169704a/</id><summary type="html">...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Auctions"></category><category term="Food Safety"></category><category term="United States"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Western Europe"></category><category term="Shropshire"></category><category term="Bristol"></category><category term="RSPCA"></category><category term="Compassion in World Farming"></category><category term="Soil Association"></category><category term="Food Standards Agency"></category><category term="Genetic Engineering"></category><category term="Smiddiehill Holsteins"></category><category term="Joyce D'Silva"></category></entry><entry><title>European Officals Raid Big Pharma in Generics Probe</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/european-officals-raid-big-pharma-generics-probe-2876408a" rel="alternate"></link><updated>2010-10-22T17:52:57Z</updated><author><name>Wall Street Journal Health Blog</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/pharmaceuticals-sector/european-officals-raid-big-pharma-generics-probe-2876408a/</id><summary type="html">...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Commission"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Neelie Kroes"></category><category term="European Federation of Pharmaceutical Industries"></category></entry><entry><title>Europe Not Ready for Consumer Drug Ads</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/europe-ready-consumer-drug-ads-2872699a" rel="alternate"></link><updated>2010-10-22T17:10:30Z</updated><author><name>Wall Street Journal Health Blog</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/pharmaceuticals-sector/europe-ready-consumer-drug-ads-2872699a/</id><summary type="html">...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Advertising and Related Services"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Schering-Plough Corporation"></category><category term="Sepracor Inc."></category><category term="AstraZeneca Group"></category><category term="Western Europe"></category><category term="Lunesta"></category><category term="Nasonex"></category><category term="Dow Jones &amp; Co. Inc."></category><category term="David Brennan (Executive)"></category><category term="Fred Hassan"></category><category term="England"></category><category term="London (England)"></category></entry><entry><title>Novartis says European regulators have approved its Exelon skin patch to treat Alzheimer's</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/novartis-european-regulators-approved-exelon-skin-patch-treat-alzheimers-1212198a" rel="alternate"></link><updated>2010-09-09T23:13:01Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-09-09:/pharmaceuticals-sector/novartis-european-regulators-approved-exelon-skin-patch-treat-alzheimers-1212198a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The drugmaker &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis AG&lt;/a&gt; said Monday that the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; had approved its &lt;a title="Exelon Corporation" href="/topic/Exelon+Corporation" &gt;Exelon&lt;/a&gt; skin patch to treat Alzheimer's disease.&lt;/p&gt;&lt;p&gt;The patch, which was approved in the &lt;a title="United States" href="/topic/United+States" &gt;United States&lt;/a&gt; by the &lt;a title="Food and Drug Administration" href="...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="Novartis AG"></category><category term="Exelon Corporation"></category></entry><entry><title>Novartis: EU approves Alzheimer's patch</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/novartis-eu-approves-alzheimers-patch-1211575a" rel="alternate"></link><updated>2010-09-09T23:07:27Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-09-09:/pharmaceuticals-sector/novartis-eu-approves-alzheimers-patch-1211575a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis&lt;/a&gt; Says European Regulators Have Approved Its &lt;a title="Exelon Corporation" href="/topic/Exelon+Corporation" &gt;Exelon&lt;/a&gt; Skin Patch to Treat Alzheimer's&lt;/div&gt;&lt;div&gt;&lt;p&gt;The drugmaker Novartis AG said Monday that the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; had approved its Exelon skin patch to treat Alzheimer's disease.&lt;/p&gt;&lt;p&gt;The patch, which was approved in the &lt;a title="...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="Novartis AG"></category><category term="Exelon Corporation"></category></entry><entry><title>Life sciences and biotechnology - a strategy for Europe</title><link href="http://biotechresearchinfo.com/biotechnology/life-sciences-biotechnology-strategy-europe-2901437a" rel="alternate"></link><updated>2010-10-23T02:49:07Z</updated><author><name>Alternative Assets Network</name></author><id>tag:biotechresearchinfo.com,2010-10-23:/biotechnology/life-sciences-biotechnology-strategy-europe-2901437a/</id><summary type="html">...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Biotechnology Sector"></category><category term="United States"></category><category term="Europe"></category><category term="European Commission"></category></entry><entry><title>China EU</title><link href="http://biotechresearchinfo.com/photo/china-eu-2400525p" rel="alternate"></link><updated>2010-12-20T22:00:14Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-20:/photo/china-eu-2400525p/</id><summary type="html">&lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; Vice President in charge of competition policy, &lt;a title="Joaquin Almunia" href="/topic/Joaquin+Almunia" &gt;Joaquin Almunia&lt;/a&gt;, center, speaks at the 3rd &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;-&lt;a title="China" href="/topic/China" &gt;China&lt;/a&gt; High-level Economic and Trade Dialogue at the Diaoyutai State Guesthouse in &lt;a title="Beijing" href="/topic/Beijing" &gt;Beijing&lt;/a&gt; on Tuesday Decem...</summary><category term="Politics"></category><category term="World Politics"></category><category term="Asia-Pacific Politics"></category><category term="Chinese Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="European Union"></category><category term="Beijing"></category><category term="China"></category><category term="European Commission"></category><category term="Asia"></category><category term="East Asia"></category><category term="Joaquin Almunia"></category></entry><entry><title>Belgium Threatened Fish</title><link href="http://biotechresearchinfo.com/photo/belgium-threatened-fish-2397542p" rel="alternate"></link><updated>2010-12-15T04:31:22Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-15:/photo/belgium-threatened-fish-2397542p/</id><summary type="html">File - In this Oct. 16, 2009 file photo, &lt;a title="Fernand Pawels" href="/topic/Fernand+Pawels" &gt;Fernand Pawels&lt;/a&gt;, of the &lt;a title="Verbiest Fish Company" href="/topic/Verbiest+Fish+Company" &gt;Verbiest Fish Company&lt;/a&gt;, unpacks a crate of fresh Codfish at the company warehouse in &lt;a title="Antwerp" href="/topic/Antwerp" &gt;Antwerp&lt;/a&gt;, &lt;a title="Belgium" href="/topic/Belgium" &gt;Belgium&lt;/a&gt;. &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; nations on Tuesday, Dec. 14, 2010...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Animal Production"></category><category term="Commercial Fishing"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Antwerp"></category><category term="Virginia Mayo"></category><category term="Verbiest Fish Company"></category><category term="Fernand Pawels"></category></entry><entry><title>Belgium EU Greece</title><link href="http://biotechresearchinfo.com/photo/belgium-eu-greece-2393097p" rel="alternate"></link><updated>2010-12-06T09:01:43Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-06:/photo/belgium-eu-greece-2393097p/</id><summary type="html">&lt;a title="European Commission" href="/topic/European+Commission" &gt;EU Commission&lt;/a&gt; President &lt;a title="Jose Manuel Barroso" href="/topic/Jose+Manuel+Barroso" &gt;Jose Manuel Barroso&lt;/a&gt;, right, welcomes &lt;a title="George Papandreou" href="/topic/George+Papandreou" &gt;Greek Prime Minister George Papandreou&lt;/a&gt; upon his arrival at the EU Commission headquarters in &lt;a title="Brussels" href="/topic/Brussels" &gt;Brussels&lt;/a&gt;, Monday Dec. 6, 2010. (AP Photo/Geert Vanden Wijngaert)&lt;div id="copyright"&gt;&lt;div&gt;
  ...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="Balkan Politics"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Jose Manuel Barroso"></category><category term="George Papandreou"></category><category term="Greek Politics"></category></entry><entry><title>Belgium EU Economy</title><link href="http://biotechresearchinfo.com/photo/belgium-eu-economy-2390416p" rel="alternate"></link><updated>2010-12-01T08:03:09Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-01:/photo/belgium-eu-economy-2390416p/</id><summary type="html">European Commissioner for Competition &lt;a title="Joaquin Almunia" href="/topic/Joaquin+Almunia" &gt;Joaquin Almunia&lt;/a&gt; addresses the media at the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; headquarters in &lt;a title="Brussels" href="/topic/Brussels" &gt;Brussels&lt;/a&gt;, Wednesday, Dec. 1, 2010. Crisis-hit banks seeking state aid next year will have to overhaul their operations as part of a strategy to wean them off state support, the &lt;a title="European Union" ...</summary><category term="Media"></category><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Price Controls and Subsidies"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Joaquin Almunia"></category></entry><entry><title>Europe-Financial Crisis</title><link href="http://biotechresearchinfo.com/photo/europefinancial-crisis-2363300p" rel="alternate"></link><updated>2010-10-13T09:32:35Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-10-13:/photo/europefinancial-crisis-2363300p/</id><summary type="html">FILE - In this Thursday, Sept. 16, 2010 file photo European Council President Herman Van Rompuy speaks during a media conference after an &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; summit in &lt;a title="Brussels" href="/topic/Brussels" &gt;Brussels&lt;/a&gt;. After months of agonizing, leaders of the European Union are closing in on new oversight rules to ensure sound finances, prevent another government debt crisis and restore the credibility of the euro. But governments are starting t...</summary><category term="Economic Issues"></category><category term="Politics"></category><category term="Local Politics"></category><category term="Political Policy"></category><category term="International Relations"></category><category term="Diplomacy"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Public Finance"></category><category term="Economic Crisis"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Herman Van Rompuy"></category><category term="Virginia Mayo"></category><category term="National Debt"></category></entry></feed>
